Company Filing History:
Years Active: 2013-2015
Title: Sean Connors: Innovator in Cardiomyopathy Diagnostics
Introduction
Sean Connors is a notable inventor based in St. John's, Canada. He has made significant contributions to the field of cardiology, particularly in the diagnosis and treatment of cardiomyopathy. With a focus on innovative methods and compositions, Connors has developed technologies that enhance the understanding and management of heart diseases.
Latest Patents
Connors holds 2 patents related to diagnostic tests for cardiomyopathy. His latest patents describe methods and compositions for diagnosing and treating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). These patents provide methods for screening, diagnosing, or detecting a risk of developing ARVD/C by identifying the presence of a transmembrane protein 43 (TMEM43) disease-associated variant in a subject's sample. The presence of this variant indicates that the subject has ARVD/C or an increased risk of developing the condition compared to individuals with wild type TMEM43.
Career Highlights
Throughout his career, Connors has worked with various organizations, including Genesis Group Inc. and Memorial University of Newfoundland. His work has been instrumental in advancing the field of cardiology and improving patient outcomes through innovative diagnostic techniques.
Collaborations
Connors has collaborated with notable colleagues such as Terry-Lynn Young and Kathy Hodgkinson. These partnerships have contributed to the development of his groundbreaking patents and research in cardiomyopathy.
Conclusion
Sean Connors is a distinguished inventor whose work in cardiomyopathy diagnostics has the potential to significantly impact patient care. His innovative approaches and collaborations highlight the importance of research in advancing medical science.